Nosocomial pneumonia in the thanatogenesis of patients with severe non-pulmonary disease
https://doi.org/10.18093/0869-0189-2011-0-6-58-61
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Summary. A retrospective analysis of clinical, radiological, laboratory and postmortem findings of 74 cases of nosocomial pneumonia (13.8 % of 536 autopsies performed for 5 years) has been carried out. Seriously ill patients died of nosocomial pneumonia alone (28 cases, or 37.8 %) or of another primary disease (13 cases, or 17.6 %), or of their combination (33 cases, or 44.6 %) have been examined. Sixteen significant correlation links between clinical and laboratory parameters were found. This allowed evaluation of those parameters in term of therapeutic strategy and prognosis of nosocomial pneumonia. Bacterial colonization of pleural effusion and/or of pulmonary parenchyma was found in all the cases and was considered as a sign of immune suppression. This could provide rationale for development and implementation of preventive measures of nosocomial pneumonia in certain patients using vaccines or immune modulators.
About the Authors
I. I. DantsigRussian Federation
I. M. Skipsky
Russian Federation
N. F. Levin
Russian Federation
A. P. Melnikova
Russian Federation
References
1. Gel'fand B.R., Belotserkovskii B.Z., Protsenko D.N., Ignatenko O.V. Nozokomial'naya pnevmoniya u bol'nykh v otdelenii reanimatsii i intensivnoi terapii: diagnostika i antimikrobnaya khimioterapiya. Consilium Medicum 2008; 10 (3): 40-43.
2. American Thoracic Society and the Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171 (4): 388-416.
3. Domnikova N.P., Sidorova L.D., Nepomnyashchikh G.I. Vnutribol'nichnye pnevmonii: patomorfogenez, osobennosti kliniki i terapii, kriterii prognoza. M.: Izd-vo RAMN, 2003.
4. Sinopal'nikov A.I. Gospital'naya pnevmoniya: taktika antibakterial'noi terapii. Antibiotiki i khimioter. 1999; 44 (11): 44-48.
5. Alp E., Guven M., Yildiz O. et al. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann. Clin. Microbiol. Antimicrob. 2004; 3: 17.
6. Baigozina E.A., Sovalkin V.I. Sovremennye osobennosti antibakterial'noi terapii nozokomial'noi pnevmonii. Ter. arkh. 2008; 80 (3): 59-62.
7. Cunha B.A. Multi-Drug Resistant (MDR) Klebsiella, Acinetobacter, and Pseudomonas aeruginosa. Antibiot. Clin. 2006;10: 354-355.
8. Chuchalin A.G., Sinopal'nikov A.I., Strachunskii L.S. i dr. Nozokomial'naya pnevmoniya u vzroslykh: prakticheskie rekomendatsii po diagnostike, lecheniyu i profilaktike (posobie dlya vrachei). Klin. mikrobiol. i antimikrob. khimioter. 2005; 7 (1): 4-30.
9. Niederman M.S. Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences. Semin. Respir. Infect. 1990; 5: 173-184.
Review
For citations:
Dantsig I.I., Skipsky I.M., Levin N.F., Melnikova A.P. Nosocomial pneumonia in the thanatogenesis of patients with severe non-pulmonary disease. PULMONOLOGIYA. 2011;(6):58-61. (In Russ.) https://doi.org/10.18093/0869-0189-2011-0-6-58-61
ISSN 2541-9617 (Online)